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Abstract Polycomb group (PcG) proteins function as chromatin-based transcriptional repressors
that are essential for normal gene regulation during development. However, how these systems
function to achieve transcriptional regulation remains very poorly understood. Here, we discover
that the histone H2AK119 E3 ubiquitin ligase activity of Polycomb repressive complex 1 (PRC1) is
defined by the composition of its catalytic subunits and is highly regulated by RYBP/YAF2-
dependent stimulation. In mouse embryonic stem cells, RYBP plays a central role in shaping
H2AK119 mono-ubiquitylation at PcG targets and underpins an activity-based communication
between PRC1 and Polycomb repressive complex 2 (PRC2) which is required for normal histone H3
lysine 27 trimethylation (H3K27me3). Without normal histone modification-dependent
communication between PRC1 and PRC2, repressive Polycomb chromatin domains can erode,
rendering target genes susceptible to inappropriate gene expression signals. This suggests that
activity-based communication and histone modification-dependent thresholds create a localized
form of epigenetic memory required for normal PcG chromatin domain function in gene regulation.
DOI: 10.7554/eLife.18591.001
Introduction
In multicellular eukaryotes the capacity to express defined subsets of genes at the correct time and
place underpins normal development. While genetically encoded regulatory pathways define the
nature of these gene expression patterns in individual cell types and tissues, these systems must ulti-
mately converge on a DNA substrate that is not unadorned, but instead wrapped around histone
proteins to form nucleosomes and chromatin. Through studying chromatin function in the context of
gene regulatory networks it is now clear that modification of DNA and histones is essential for con-
trolling normal regulation of gene expression (Bannister and Kouzarides, 2011).
In animals, Polycomb group (PcG) proteins play central roles in gene regulation through their
chromatin modifying activities. First identified in Drosophila as important regulators of body plan
specification, orthologous PcG systems were subsequently identified in vertebrates and also shown
to be essential for developmental gene regulation (Lewis, 1978; Schwartz and Pirrotta, 2013). Bio-
chemical characterization of PcG proteins has revealed that they form large multiprotein complexes
that function as chromatin-modifying or -remodelling enzymes (Mu¨ller and Verrijzer, 2009;
Simon and Kingston, 2013). PcG proteins generally fall into one of two multiprotein complexes,
called Polycomb repressive complex 1 and 2 (PRC1 and PRC2). PRC1 functions as a histone E3 ubiq-
uitin ligase that mono-ubiquitylates histone H2A at position 119 (H2AK119ub1) (Cao et al., 2005;
de Napoles et al., 2004; Wang et al., 2004a) and PRC2 is a histone H3 lysine 27 (H3K27)
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methyltransferase (Cao et al., 2002; Czermin et al., 2002; Mu¨ller et al., 2002; Margueron and
Reinberg, 2011). Together, the activities of these two PcG protein complexes play important roles
in maintaining repressive chromatin states and controlling gene expression during cell fate transi-
tions (Xie et al., 2013; Arnold et al., 2013; Boyer et al., 2006; Leeb and Wutz, 2007;
Endoh et al., 2008; Terranova et al., 2008; Koche et al., 2008; Bracken et al., 2006).
The defined molecular mechanisms that underpin how PcG complexes regulate transcription still
remain poorly understood. However, it has been proposed that the occupancy of PRC1 and PRC2 at
genomic target sites and their capacity to modify histones may function to create structurally com-
pacted chromatin which is inhibitory to transcription (Eskeland et al., 2010; Francis et al., 2004;
Wani et al., 2016; Boettiger et al., 2016). To achieve this, the function of PRC1 and PRC2 appear
to be intimately linked. For example, some PRC1 complexes are able to recognise and bind PRC2-
dependent H3K27me3, recruiting those PRC1 complexes to sites occupied by PRC2
(Min et al., 2003; Wang et al., 2004b). Similarly, PRC2 can recognize PRC1-deposited
H2AK119ub1, regulating PRC2 occupancy on chromatin (Blackledge et al., 2014; Cooper et al.,
2014). Furthermore, in vitro assays have suggested that H2AK119ub1 may also stimulate the enzy-
matic activity of PRC2 (Kalb et al., 2014). Based on these observations it has been proposed that
feedback mechanisms, whereby one Polycomb repressive complex supports the recruitment and
possibly activity of the other complex, may in part underpin chromatin-based transcriptional repres-
sion (Blackledge et al., 2015; Steffen and Ringrose, 2014; Voigt et al., 2013). In other scenarios
the relevance of histone modifications to gene repression, particularly the role of H2AK119ub1, has
remained unclear, with the repressive nature of PRC1 being proposed to reside within its capacity to
alter chromatin structure and compaction independently of its H2A ubiquitylating activity
(Pengelly et al., 2015; Illingworth et al., 2015; Francis et al., 2004; Eskeland et al., 2010). How-
ever in most cases, the defined contribution of H2AK119ub1-dependent and –independent path-
ways, and their relevance to Polycomb chromatin domain function in vivo have remained
incompletely defined.
In order to understand the mechanisms by which the PcG systems function together in vivo, it will
be critical to discover how, if at all, their enzymatic activities contribute to chromatin structure and
gene regulation. While significant effort has been placed on understanding in vitro how the H3K27
methyltransferase activity of PRC2 is controlled (Margueron et al., 2009; Jiao and Liu, 2015;
Cao and Zhang, 2004), far less is known about how PRC1 complexes catalyse H2AK119ub1 and
how this relates to the function of PRC1 in vivo. This paucity in our understanding of PRC1 activity is
in part due to the diverse nature of individual PRC1 complexes. At the simplest level, PRC1 com-
plexes are formed by their catalytic subunit, RING1A or RING1B, which dimerises with a PCGF pro-
tein to form an active E3 ubiquitin ligase that targets histone H2A (Levine et al., 2002; Satijn et al.,
1997). In mammals, there are six PCGF proteins (PCGF1–6), and the identity of the PCGF protein
incorporated into PRC1 appears to direct interaction with a specific complement of auxiliary pro-
teins, giving rise to an array of diverse PRC1 complexes (Blackledge et al., 2014; Gao et al., 2012;
Tavares et al., 2012). Based on the protein subunit composition of these individual PRC1 com-
plexes, they are often then divided into ‘canonical’ or ‘variant’ complexes. Canonical PRC1 com-
plexes form around either PCGF2 or 4, and incorporate a chromobox (CBX) protein, which can
directly bind to PRC2-catalysed H3K27me3 (Fischle et al., 2003; Bernstein et al., 2006; Min et al.,
2003). In contrast, variant PRC1 complexes can form around all six PCGF proteins, but these com-
plexes engage with RYBP or YAF2, two proteins that bind to a site on RING1B that is mutually exclu-
sive with CBX protein binding (Garcı´a et al., 1999; Wang et al., 2010).
Despite the diversity of PRC1 complexes, biochemical characterization of their catalytic activity
has largely been focused on canonical PCGF2/PCGF4-containing complexes (Li et al., 2006;
Gao et al., 2012; Elderkin et al., 2007; Cao et al., 2005; Buchwald et al., 2006; Ben-
saadon et al., 2006). For example, in vitro ubiquitylation assays using reconstituted complexes and
nucleosome substrates demonstrated that RING1(A/B) could form an active E3 ligase in the pres-
ence of either PCGF2 or PCGF4 (Elderkin et al., 2007; Buchwald et al., 2006). Furthermore, a mini-
mal complex comprised of a dimer between the N-terminal RING finger domains of PCGF4 and
RING1B was sufficient to deposit H2AK119ub1 (Buchwald et al., 2006). Importantly, the RING fin-
ger domains of individual PCGF proteins are highly similar, suggesting that they will likely all support
formation of an active E3 ligase complex. However, more recent work examining PCGF(1–6)/RING1
(A/B) catalytic RING-RING dimers revealed that PCGF(2/4)/RING1(A/B) were less active than PCGF
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(1/3/5/6)/RING1(A/B) in autoubiquitylation and E2 lysine discharge assays (Taherbhoy et al., 2015).
Surprisingly, when these same assemblies were challenged with physiologically relevant nucleosome
substrates, complex-specific activities were no longer apparent. Nevertheless, consistent with the
possibility that individual PRC1 complexes may have distinct activities related to protein complex
composition, in vivo studies in both mammals and Drosophila have suggested that less-well charac-
terized variant PRC1 complexes may contribute more significantly to H2A mono-ubiquitylation than
canonical PRC1 (Tavares et al., 2012; Lee et al., 2015; Lagarou et al., 2008; Blackledge et al.,
2014). For example, the Drosophila dRAF complex, which appears to have similarities to mammalian
variant PRC1 complexes, is a highly active H2A ubiquitin ligase in vitro and appears to be the pre-
dominant H2A ubiquitin ligase in Drosophila S2 cells (Lagarou et al., 2008). Furthermore, a PCGF3
orthologue contributes widely to H2AK119ub1 in cultured Drosophila cells (Lee et al., 2015). This
raises the possibility that individual PCGF proteins might confer differing E3 ligase activities on
PRC1, either directly, or via interaction with complex-specific regulatory subunits. Indeed, incorpo-
ration of the auxiliary subunits RYBP, PHC2 or CBX2/8 into a PCGF4/RING1B complex has been
reported to affect its E3 ligase activity in different ways (Gao et al., 2012), though this was not the
case for PCGF2/RING1B, in which auxiliary subunits had little impact on catalytic activity
(Tavares et al., 2012). Therefore a more detailed understanding of how H2AK119 ubiquitin ligase
activity is shaped by different PRC1 assemblies, both in vitro and in vivo, is required to better under-
stand PRC1 involvement in polycomb chromatin domain function and gene regulation.
To address these important questions we have exploited biochemical and genomic approaches
to interrogate PRC1 enzymatic activity in vitro and in cells. This revealed that PRC1 complexes are
highly modular, and that the enzymatic activity of PRC1 is defined by the choice of PCGF protein
combined with the influence of RYBP/YAF2, uncovering an enzymatic logic within the assembly of
individual PRC1 complexes. Building on these discoveries, genetic ablation and genomic approaches
uncover a widespread role for RYBP in stimulating H2AK119 E3 ligase activity in vivo, and we dem-
onstrate that the absence of this activity leads to defects in the deposition of H3K27me3 by PRC2.
Importantly, in the absence of RYBP, loss of PRC1 stimulation and subsequent defects in PRC2 activ-
ity can lead to erosion of Polycomb chromatin domains and susceptibility to inappropriate gene acti-
vation signals. Together, these observations identify an activity-based communication between
PRC1 and PRC2 in vivo, and suggest that histone modification-dependent thresholding mechanisms
sustain Polycomb chromatin domains, connecting the activity of PcG systems to their occupancy on
chromatin and transcriptional repression.
Results
PCGF1-PRC1 is a highly modular protein complex
In embryonic cells and tissues where the PcG system is thought to play a pivotal role in developmen-
tal gene regulation, the PCGF1-PRC1 complex is highly abundant (Kloet et al., 2016), and is
required for H2AK119ub1 and normal development (Farcas et al., 2012; Blackledge et al., 2014;
Gao et al., 2012; He et al., 2013; Wu et al., 2013; Gearhart et al., 2006; Boulard et al., 2015).
Furthermore, tethering experiments had previously suggested that the variant PCGF1 complex
might be more active than PCGF2/4 complexes in vivo (Blackledge et al., 2014). Given the essential
nature of this PRC1 complex and its apparent elevated activity in vivo, we sought to use it as a
model system to understand the biochemical mechanisms that underpin the assembly and catalytic
activity of PRC1. To achieve this, we used a baculovirus co-expression system (Bieniossek et al.,
2012) to assemble and affinity-purify the five component PCGF1-PRC1 holocomplex containing
RING1B, PCGF1, RYBP, KDM2B and BCOR (Figure 1A and B). To understand in more detail the
topology of the PCGF1-PRC1 complex we subjected it to crosslinking followed by tandem mass
spectrometry analysis, which identifies the relative proximity of proteins within large protein complex
assemblies (Leitner et al., 2014). This revealed clear spatial relationships between individual compo-
nents of the complex (Figure 1C). For example, RING1B was in close proximity to PCGF1 and RYBP.
Importantly RING1B and RYBP crosslinks were consistent with atomic resolution information detail-
ing their physical interaction (Figure 1—figure supplement 1) (Wang et al., 2010). BCOR and
KDM2B crosslinked extensively with each other suggesting they are in close proximity and also dis-
played additional crosslinks with PCGF1 and RYBP. However, there was no evidence for significant
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Figure 1. PCGF1-PRC1 is a highly modular complex. (A) A schematic of the PCGF1-PRC1 complex indicating the core catalytic dimer of RING1B and
PCGF1 and auxiliary components RYBP, KDM2B, and BCOR. (B) A Coomassie-stained gel of PCGF1-PRC1 affinity-purified via RING1B. Individual
subunits are labelled and * denotes contaminants HSP70 and b-tubulin. (C) A Circos plot illustrating crosslinking mass spectrometry analysis of the
PCGF1-PRC1 complex reveals extensive interactions between PCGF1-PRC1 subunits. Blue and orange lines indicate intermolecular and intramolecular
crosslinks respectively. Lines are weighted by the statistical confidence of their interaction. (D) Coomassie-stained gels of affinity-purified PCGF1-PRC1
sub-complexes demonstrating the modularity of PCGF1-PRC1 complex. Complexes were affinity-purified via RING1B. Above each lane (i-vi) the co-
expressed factors are illustrated and * denotes contaminants HSP70 and b-tubulin.
DOI: 10.7554/eLife.18591.002
The following figure supplement is available for figure 1:
Figure supplement 1. Crystal structure validation of crosslinking mass spectrometry-identified proximities.
DOI: 10.7554/eLife.18591.003
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crosslinks between either BCOR or KDM2B and RING1B, suggesting they are not in close proximity
within the complex. This suggests a high degree of modularity within the PCGF1-PRC1 complex,
where individual combinations of proteins engage extensively with each other, while others exhibit
little or no clear proximity.
Based on the apparent modularity of PCGF1-PRC1, we set out to dissect the requirement for indi-
vidual components in its assembly. To achieve this we generated a series of co-expression vectors in
which individual proteins were iteratively omitted (Figure 1D). This revealed that KDM2B and BCOR,
which appear to interact with the complex through PCGF1 (Figure 1C), can be completely removed,
either individually or in combination, to leave an intact PCGF1-RING1B-RYBP sub-complex
(Figure 1D(i–iii)). Similarly, when RYBP was removed from the PCGF1-PRC1 complex, BCOR and
KDM2B were still able to independently interact with the PCGF1-RING1B dimer (Figure 1D(iv–v)).
This indicates that inclusion of BCOR and KDM2B in the PCGF1-PRC1 complex does not require
RYBP, or an interaction with each other. Finally, in agreement with analysis of other PCGF/RING1
interactions, PCGF1/RING1B formed dimers in the absence of other PCGF1-PRC1 components
(Figure 1D(vi)). Therefore, the PCGF1-PRC1 holocomplex assembles around a core PCGF1-RING1B
dimer, and does so in a highly modular fashion. Interestingly, in Drosophila, the related dRAF com-
plex exhibits similar modularity (Lagarou et al., 2008). This contrasts the assembly of the PRC2 holo-
complex, which appears to rely on extensive and highly integrated protein-protein interactions for
its efficient formation (Ciferri et al., 2012; Jiao and Liu, 2015).
RYBP/YAF2 stimulates H2A ubiquitylation by PCGF1-PRC1
Within multiprotein enzyme complexes, non-catalytic components can function to regulate enzy-
matic activity, substrate recognition, or targeting. Our understanding of how PRC1 complexes func-
tion in these regards remains very poorly defined. However, the inherent modularity of the PCGF1-
PRC1 complex provided a unique opportunity to examine if individual components of the complex
contribute to the H2AK119 E3 ligase activity of PRC1. To address this important question, we first
established a quantitative in vitro E3 ligase activity assay using nucleosome substrates and confirmed
that reconstituted PCGF1-PRC1 was active by detecting the conversion of H2A to mono-ubiquity-
lated H2A (Figure 2A). We then compared the relative E3 ligase activity of the PCGF1-RING1B core
dimer to the five component PCGF1-PRC1 holocomplex (Figure 2B). Surprisingly, the PCGF1-PRC1
holocomplex was substantially more active than the PCGF1-RING1B core (Figure 2B). To understand
the molecular determinants controlling this activity, we then iteratively measured the H2AK119 E3
ligase activities of individual PCGF1-PRC1 sub-complexes (Figure 2C). This revealed that interaction
of RYBP with the RING1B-PCGF1 core dimer was responsible for elevated enzymatic activity of the
PCGF1-PRC1 holocomplex. In contrast, KDM2B and BCOR appeared to contribute little or nothing
to this activity, suggesting that they confer alternative, non-enzymatic functions to the PRC1 com-
plex. Variant PRC1 complexes can contain either RYBP or YAF2, and their inclusion appears to be
mutually exclusive, presumably because they bind to the same region of RING1B (Gao et al., 2012;
Wang et al., 2010; Tavares et al., 2012). Given the stimulatory activity of RYBP on PRC1, we
wanted to determine whether YAF2 was also capable of stimulating PCGF1-RING1B. Therefore, we
purified recombinant YAF2 and RYBP and added them to PCGF1-RINGB E3 ligase reactions (Fig-
ure 2—figure supplement 1A). Importantly, this revealed that YAF2 also stimulated PCFG1-RING1B
activity (Figure 2—figure supplement 1B). Together these observations reveal that RYBP and YAF2
regulate PCGF1-PRC1 activity in vitro, where they act to stimulate the PCGF1-RING1B core dimer
and enhance H2AK119ub1 deposition.
The activity of PRC1 complexes is defined by their PCGF component
and RYBP-dependent stimulation
Ectopic targeting of PRC1 complexes to chromatin in vivo had suggested that PCGF1-PRC1 is more
efficient at depositing H2AK119ub1 on chromatin than PCGF4-PRC1 (Blackledge et al., 2014).
Therefore, we sought to understand whether differences in E3 ligase activity between individual
PRC1 complexes are inherent to the PCGF-RING1B catalytic core, or whether RYBP may have selec-
tive stimulatory activity. This was important as previous in vitro work had only directly compared the
H2AK119ub1 E3 ligase activity of differing PCGF/RING1 assemblies in the context of minimal RING-
RING catalytic dimers (Taherbhoy et al., 2015). Furthermore, when intact PCGF(2/4)/RING1 dimers
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had been examined, differing conclusions were made as to whether RYBP stimulated E3 ligase activ-
ity (Tavares et al., 2012; Gao et al., 2012). Therefore to examine these points in more detail, we
expressed and purified intact PCGF1-RING1B and PCGF4-RING1B dimers and compared their rela-
tive activities in H2AK119 E3 ligase assays (Figure 3A). Interestingly, this revealed that PCGF1-
RING1B was significantly more active than PCGF4-RING1B (Figure 3B), indicating that the enzymatic
activity of a given PRC1 complex is inherently defined by the PCGF-RING dimer which forms its cata-
lytic core. Given that PCGF1-RING1B is robustly stimulated by RYBP, we were then curious to under-
stand whether RYBP stimulated PCGF4-RING1B. This was an important question as previous studies
examining the effect of RYBP on PCGF4-RING1B and the related PCGF2-RING1B dimer had come
to differing conclusions, with one study observing no effect on activity and the other claiming
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Figure 2. RYBP stimulates the catalytic core of PCGF1-PRC1. (A) A histone H2AK119 E3 ligase assay monitoring the conversion of H2A to mono-
ubiquitylated H2A by western blotting, which demonstrates that the activity of PCGF1-PRC1 requires E1 (UBE1), E2 (UBCH5C), Ubiquitin and ATP. The
top panel monitors H2A mono-ubiquitylation with an antibody against total H2A that detects both mono-ubiquitylated and non-ubiquitylated H2A. The
bottom panel monitors production of mono-ubiquitylated H2A with an antibody that specifically recognizes H2AK119ub1. (B) An E3 ligase activity assay
directly comparing the PCGF1-RING1B catalytic core and the PCGF1-PRC1 holocomplex over increasing enzyme concentrations (two fold dilution
series) as examined by western blotting. (C) An E3 ligase activity assay comparing the PCGF1-PRC1 holocomplex and various sub-complexes in which
individual and combinations of PCGF1-PRC1 subunits have been omitted (see Figure 1D). This demonstrates that RYBP is the central determinant of E3
ligase activity for the PCGF1-PRC1 complex. The error bars correspond to the S.E.M. of at least two independent experiments.
DOI: 10.7554/eLife.18591.004
The following figure supplement is available for figure 2:
Figure supplement 1. YAF2 stimulates PCGF1-RING1B E3 ligase activity.
DOI: 10.7554/eLife.18591.005
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elevated H2AK119 E3 ligase activity (Gao et al., 2012; Tavares et al., 2012). In the context of our
experiments, we observe a small stimulatory effect when RYBP was added to PCGF4-RING1B
(Figure 3B). Despite this low level of stimulation, PCGF4-RING1B-RYBP was still much less active
than PCGF1-RING1B-RYBP. Together these observations indicate that the PCGF component of the
PRC1 complexes defines the inherent H2AK119 E3 ligase activity of individual PRC1 dimers and that
inclusion of RYBP/YAF2 further matures these assemblies into robust enzymes that can efficiently
modify chromatin.
RYBP-dependent stimulation of PCGF1-PRC1 is associated with changes
in the PCGF1-RING1B dimer but not with ubiquitin binding
Our in vitro reconstitution reactions demonstrated that RYBP can control how PRC1 deposits
H2AK119ub1. We were therefore interested to understand the molecular nature of this stimulatory
activity, as it could have profound implications for how PRC1 functions in vivo. Interestingly, RYBP
has been shown to function as an ubiquitin-binding protein via its zinc finger NZF domain
(Arrigoni et al., 2006; Fereres et al., 2014). We therefore reasoned that the capacity of RYBP to
recognize ubiquitin, perhaps in the form of H2AK119ub1, could account for its stimulatory activity
on PRC1. To examine this possibility we generated recombinant RYBP, and RYBP with mutations in
the NZF domain that abrogate ubiquitin binding (Arrigoni et al., 2006), and added them to E3
ligase reaction containing PCGF1-RING1B (Figure 4A and B). Importantly, both forms of RYBP stim-
ulated the activity of PCGF1-RING1B to a similar extent (Figure 4B). Given that the ability of RYBP
to recognise ubiquitin did not account for its stimulation of PRC1, we wondered whether RYBP may
instead affect how the core dimer assembles to function as an H2AK119 E3 ligase. We therefore
turned to crosslinking mass spectrometric analyses to examine whether inclusion of RYBP in the com-
plex resulted in any gross alterations in the proximity of individual domains. To address this possibil-
ity we directly compared the PCGF1-RING1B dimer (Figure 4C) and the RYBP-PCGF1-RING1B
trimer (Figure 4D). Within the PCGF1-RING1B dimer, we observed multiple high-confidence cross-
links between the RING domain of RING1B and its C-terminal ubiquitin-like (UBL) domain,
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Figure 3. The PCGF1 catalytic dimer is inherently more active and stimulated more robustly than the PCGF4 catalytic dimer. (A) Coomassie-stained
gels showing the recombinant PCGF1-RING1B or PCGF4-RING1B catalytic cores with or without the addition of RYBP. Complexes were affinity-purified
via RING1B. PCGF4 and RING1B migrate at the same position on the gel (Figure 3—figure supplement 1). (B) An E3 ligase activity assay comparing
PCGF1-RING1B or PCGF4-RING1B in the presence or absence of RYBP. The error bars correspond to the S.E.M. of at least two independent
experiments.
DOI: 10.7554/eLife.18591.006
The following figure supplement is available for figure 3:
Figure supplement 1. Resolution of RING1B/PCGF4 dimer by SDS-PAGE.
DOI: 10.7554/eLife.18591.007
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suggesting that there are likely significant intramolecular interactions occurring between these
regions (Figure 4C). Intriguingly, most of the RING domain/RING-UBL domain crosslinks within
RING1B were lost in the trimeric complex (PCGF1-RING1B-RYBP) (Figure 4D), suggesting that RYBP
causes an alteration in PCGF1-RING1B which limits association between its N- and C-terminal
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Figure 4. RYBP-dependent stimulation of PCGF1-PRC1 is associated with changes in the PCGF1-RING1B dimer but not ubiquitin binding. (A)
Coomassie-stained gels showing the recombinant PCGF1-RING1B affinity purified via RING1B with wildtype RYBP or a ubiquitin-binding mutant (RYBP
TFAA). (B) An E3 ligase activity assay comparing the activity of PCGF1-RING1B with addition of RYBP or RYBP with mutations in the NZF domain (TF-
AA) that abrogate ubiquitin binding. Error bars correspond to the S.E.M. of at least two independent experiments. (C–D) Circos plots illustrating
crosslinking mass spectrometry analysis of PCGF1-RING1B in presence or absence of RYBP. In (C) extensive intramolecular crosslinks are observed
between the RING1B RING and UBL domains. In (D) these intramolecular crosslinks are largely ablated in the presence of RYBP which makes extensive
crosslinks with these regions of RING1B. Blue and orange lines indicate intermolecular and intramolecular crosslinks respectively. Lines are weighted by
the statistical confidence of their interaction.
DOI: 10.7554/eLife.18591.008
The following figure supplement is available for figure 4:
Figure supplement 1. PCGF1 levels are reduced in complexes lacking RYBP.
DOI: 10.7554/eLife.18591.009
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domains, possibly to stabilize the formation of an optimally assembled and active E3 ligase. Interest-
ingly, upon closer inspection of our reconstituted complexes (Figure 1D), it was noticed that the
level of PCGF1 was reduced in complexes lacking RYBP (Figure 4—figure supplement 1). This is in
agreement with our crosslinking mass spectrometry analysis, and suggests that RYBP helps to recon-
figure and stabilize the PCGF1-RING1B dimer. Importantly however, reduced PCGF1 inclusion does
not explain the effect that RYBP has on the activity of PCGF1/PRC1 complexes, as the presence of
RYBP stimulated the relative activity of PRC1 to a much larger extent than can be simply explained
by PCGF1 levels alone (Figure 2B and C). Furthermore, RYBP and YAF2 were able to significantly
stimulate the activity of pre-existing PCGF1-RING1B assemblies (Figure 2—figure supplement 1B).
Future structural work will be imperative to understand the defined biochemical nature of this RYBP-
dependent stimulation.
RYBP is required for H2AK119ub1 at PRC1 targets in vivo
The mechanisms that drive and shape H2AK119ub1 in vivo remain very poorly understood. Given
our observation that RYBP and YAF2 play a central role in controlling PRC1 complex activity in vitro,
we sought to understand whether this activity defines H2AK119ub1 in vivo. To address this possibil-
ity, we took advantage of a mouse embryonic stem cell system in which the Rybp gene is flanked by
loxP sites and which also expresses a tamoxifen-inducible form of Cre recombinase (Hisada et al.,
2012). However, this cell line also expresses the RYBP paralogue YAF2, which appears to stimulate
PRC1 in a manner similar to RYBP (Figure 2—figure supplement 1), suggesting they could have
redundant or overlapping functions in vivo. To circumvent this limitation, we exploited CRISPR/Cas9-
based genome editing to delete two essential coding exons in Yaf2 and create a homozygous
Yaf2 /  cell line that lacked Yaf2 mRNA and protein (Figure 5—figure supplement 1A–C and
Figure 5A). Treatment of the Rybpfl/fl;Yaf2 /  cell line with tamoxifen resulted in a complete loss of
RYBP by 96 hr as assessed by western blot (Figure 5B) and at PcG targets as assessed by ChIP-seq
(Figure 5C).
Having established the Rybpfl/fl;Yaf2 /  cell line we then set out to understand if the capacity of
RYBP to stimulate PRC1 in vitro would also translate into effects on cellular H2AK119ub1 following
RYBP removal. Studying this in a cellular context could however be complicated by previous conflict-
ing observations suggesting that RING1B may, or may not, be destabilised when RYBP is removed
in ESCs (Tavares et al., 2012; Morey et al., 2013). To examine this possibility we first determined
whether loss of RYBP affected the level of RING1B. In the context or our new Rybpfl/fl;Yaf2 /
 conditional system, deletion of RYBP did not lead to an appreciable reduction in total RING1B
(Figure 5B), in agreement with our observation that PRC1 complex assembly in vitro is modular
(Figure 1D). The stability of the PRC1 complex in the absence of RYBP allowed us to then examine
the direct contribution of RYBP to H2AK119ub1 in vivo. Somewhat surprisingly, despite the dramatic
affects that RYBP has on H2AK119 E3 ligase activity in vitro, removal of RYBP did not significantly
affect total H2AK119ub1 as measured by western blot (Figure 5D and E). Again this contrasts previ-
ous observations in which shRNA-mediated knockdown of RYBP led to global reductions in
H2AK119ub1 (Tavares et al., 2012; Gao et al., 2012), and suggests that these affects may have
been the indirect result of decreased RING1B levels.
Given these observations, we reasoned that RYBP may play a more defined or locus-specific role
in regulating H2AK119ub1 as had previously been suggested from single gene analysis following
RYBP depletion in ESCs (Morey et al., 2013). To address this possibility we exploited a calibrated
ChIP-seq approach (Bonhoure et al., 2014; Hu et al., 2015; Orlando et al., 2014) to measure
H2AK119ub1 genome-wide in the Rybpfl/fl;Yaf2 /  cells, before and after RYBP ablation. Impor-
tantly, H2AK119ub1 signal in wild-type cells was highly correlated with both RING1B and RYBP occu-
pancy genome-wide (Figure 5F). Furthermore, a visual inspection of these data revealed enrichment
of H2AK119ub1 at genes associated with Polycomb-mediated repression in embryonic stem cells
(Figure 5G). When we compared the levels of H2AK119ub1 before and after RYBP removal at indi-
vidual Polycomb target sites, we observed clear reductions in H2AK119ub1 (Figure 5G), suggesting
that RYBP supports deposition of H2AK119ub1 at these genomic locations. To explore the breadth
of these affects, we identified a set of 2407 genomic regions that were enriched for H2AK119ub1.
Quantitation of H2AK119ub1 after removal of RYBP revealed widespread effects on H2AK119ub1
(Figure 5H), with approximately 45% of regions showing significant reductions in the levels of
H2AK119ub1 (1091/2407; p<0.05). However, this appeared to be an underestimation of the effect,
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Figure 5. RYBP is required for H2AK119ub1 at PRC1 targets in vivo. (A) A schematic illustrating the Rybpfl/fl;Yaf2 /  mouse embryonic stem cell model
in which the addition of tamoxifen (OHT) leads to deletion of RYBP. (B) Western blot analysis demonstrating that treatment of Rybpfl/fl;Yaf2 /  cells with
tamoxifen for 96 hr results in loss of RYBP protein. The levels of the PRC1 component, RING1B, and the PRC2 component, SUZ12, are unchanged.
TATA Box Binding Protein (TBP) is included as a loading control. (C) A genomic snapshot from RYBP ChIP-seq analysis in Rybpfl/fl;Yaf2 /  cells before
(UNT) and after 96 hr of tamoxifen treatment (OHT) showing that RYBP occupancy on chromatin is lost. (D) Western blot analysis of H2AK119ub1 in
Rybpfl/fl ESCs, compared with Rybpfl/fl;Yaf2 /  cells before (UNT) and after 96 hr tamoxifen treatment (OHT). Western blot with a histone H3-specific
antibody is shown as a loading control. (E) A quantitation of western blot analysis for H2AK119ub1 relative to histone H3 in Rybpfl/fl ESCs, compared
with RYBP/YAF2 deletion indicating no global reduction in H2AK119ub1. Errors bars indicate standard deviation for three biological replicate
experiments. (F) Genome-wide correlation of wildtype H2AK119ub1, RYBP, RING1B and H3K4me3 ChIP-seq using 10 kb windows. H2AK119ub1 ChIP-
seq correlates well with RYBP and RING1B genome-wide. (G) A genomic snapshot of calibrated H2AK119ub1 ChIP-seq in the Rybpfl/fl;Yaf2 /  mouse
embryonic stem cells before (UNT) and after 96 hr tamoxifen (OHT) treatment at two polycomb-occupied target sites indicating significant reductions in
H2AK119ub1 in the absence of RYBP. (H) A metaplot illustrating calibrated H2AK119ub1 ChIP-seq read density at peaks of H2AK119ub1 (n = 2407)
before (UNT-solid line) and after (OHT- dotted line) tamoxifen treatment. Removal of RYBP has a broad effect on H2AK119ub1. (I) A scatter plot of
normalised read densities for calibrated H2AK119ub1 ChIP-seq illustrates reduced H2AK119ub1 signal at nearly all H2AK119ub1 peaks in OHT-treated
Rybpfl/fl;Yaf2 /  cells (OHT) when compared to untreated cells (UNT). Red dots correspond to statistically significant reductions in H2AK119ub1.
Figure 5 continued on next page
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as nearly all PRC1 targets displayed reductions in H2AK119ub1, albeit below the significance thresh-
old (Figure 5I). These effects are consistent with our in vitro observations demonstrating that RYBP
shapes the E3 ligase activity of PRC1 complexes. Given the widespread reductions in H2AK119ub1
observed in ChIP-seq, it is perhaps surprising that we did not detect global alterations in
H2AK119ub1 by western blot. This is likely due to a proportion of total cellular H2AK119ub1 resid-
ing outside of classical polycomb target sites as has been proposed previously in other systems
(Lee et al., 2015; Goldknopf et al., 1975).
RYBP regulates the activity, not chromatin occupancy, of PRC1 in vivo
Although our in vitro studies provide compelling evidence that RYBP regulates PRC1 activity, previ-
ous work has suggested that RYBP may also contribute to PRC1 function through regulating its sta-
bility or targeting (Tavares et al., 2012; Gao et al., 2012). Conversely, single gene studies had
suggested that following depletion of RYBP, RING1B targeting to polycomb sites may not be overtly
affected (Hisada et al., 2012; Morey et al., 2013). Therefore, having demonstrated that the stability
of PRC1 is unaffected following RYBP deletion in the Rybpfl/fl;Yaf2 /  cells (Figure 5B), we set out to
test at the genome-scale whether H2AK119ub1 losses following RYBP deletion in vivo were the
result of defective PRC1 targeting or supressed E3 ligase activity. To achieve this, we carried out
RING1B ChIP-seq before and after tamoxifen treatment of Rybpfl/fl;Yaf2- /  cells (Figure 6). Initially,
we considered RING1B occupancy at PRC1 target sites where H2AK119ub1 was dependent upon
RYBP, to examine whether H2AK119ub1 reductions were coincident with reduced chromatin occu-
pancy of PRC1. However, visual inspection of several of these sites revealed that despite displaying
large decreases in H2AK119ub1, RING1B occupancy was often unaffected (Figure 6A). We
extended this analysis genome-wide (Figure 6B), and found that the majority of PRC1 target sites
(78%; 1870/2407) failed to show a significant change in RING1B occupancy (Figure 6B) and we vali-
dated these observations at a number of sites using ChIP quantitative PCR analysis (Figure 6—fig-
ure supplement 1). Indeed, there were only a modest number of sites showing decreases in
RING1B binding (20%; 487/2407) (Figure 6C). Importantly, following RYBP deletion we observed
clear and widespread reductions in H2AK119ub1 at PRC1 target sites where RING1B occupancy
remained unchanged. These observations are in agreement previous observations at selected target
sites following shRNA-mediated knockdown of RYBP which also appeared to show loss of
H2AK119ub1 in the absence of perturbed RING1B binding (Morey et al., 2013). Interestingly, the
subset of PRC1 targets which lost RING1B appeared on average to exhibit a unique depletion of
H2AK119ub1 in the centre of the peak when compared to other PRC1 targets (Figure 6C). This was
coincident with a more highly positioned TSS at the centre of the peak but did not appear to corre-
spond with a depletion of nucleosomes (Figure 6—figure supplement 2A and B). Furthermore,
these sites tended to be more enriched for variant PRC1 (RYBP), as opposed to canonical PRC1
(CBX7) occupancy, suggesting that these PRC1 targets might depend more on RYBP for normal
H2AK119ub1 and RING1B occupancy than canonical targets (Figure 6—figure supplement 2C) as
suggested previously (Morey et al., 2013). Together, these genome-wide observations strongly sup-
port our in vitro conclusions that RYBP stimulates the E3 ligase activity of PRC1, and reveal that
decreases in H2AK119ub1 at PRC1 target sites are not due to defects in targeting PRC1.
RYBP-dependent stimulation is essential for H2AK119ub1 at sites with
low PRC1 occupancy
RYBP plays a central role in stimulating PRC1 in vivo, and virtually all H2AK119ub1-enriched regions
show some dependency on RYBP for normal H2AK119ub1 (Figure 5I). Nevertheless it was clear that
at individual sites the magnitude of H2AK119ub1 loss often differed greatly, perhaps suggesting
that features inherent to individual Polycomb target sites could dictate their reliance on the
Figure 5 continued
DOI: 10.7554/eLife.18591.010
The following figure supplement is available for figure 5:
Figure supplement 1. CRISPR-Cas9-mediateddeletion of Yaf2 in Rybpfl/fl ESCs.
DOI: 10.7554/eLife.18591.011
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stimulatory activity of RYBP. To examine this possibility we divided PRC1 target sites into quartiles
based on their relative loss of H2AK119ub1 (Figure 7A). Initially, we examined the levels of RYBP at
these different groups to determine whether the effect on H2AK119ub1 following loss of RYBP was
not simply related to the absolute amount of RYBP at a given target site (Figure 7B). Interestingly,
RYBP enrichment was similar across groups of RYBP-dependency, and counterintuitively more lowly
occupied sites often exhibited more profound reductions in H2AK119ub1. We then examined the
occupancy of the PRC1 catalytic core component RING1B at these same sites, and observed that
the sites which were most dependent upon RYBP for H2AK119ub1 had the lowest occupancy of
RING1B (Figure 7C). This suggests that sites with limiting amounts of PRC1 have a more defined
requirement for RYBP-dependent stimulation to achieve normal H2AK119ub1. To explore this possi-
bility, we calculated the ratio of RYBP relative to RING1B at PRC1 target sites over the range of
H2AK119ub1 dependencies (Figure 7D). This revealed that the sites where loss of RYBP most pro-
foundly affected H2AK119ub1 exhibited the highest ratios of RYBP to RING1B (Figure 7D and E).
At these PRC1 target sites it appears that the inherent activity of the core catalytic complex is insuffi-
cient to sustain H2AK119ub1, and that RYBP-dependent stimulation is required to define normal
H2AK119ub1 levels. We then wondered whether dependency on RYBP might also be related to the
occupancy of canonical PRC1 at these sites. Indeed, PRC1 targets that were occupied by RYBP but
displayed reduced levels of CBX7 (i.e. ‘variant-enriched’) tended to show the largest reductions in
H2AK119ub1 following RYBP removal (Figure 7F and G), whereas variant and canonical PRC1 occu-
pied sites (i.e. ‘shared’) appeared to rely on RYBP to a lesser extent. Intriguingly, shared-PRC1
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Figure 6. RYBP regulates the activity, not chromatin occupancy, of PRC1 in vivo. (A) A genomic snapshot of RING1B and H2AK119ub1 ChIP-seq in
Rybpfl/fl;Yaf2 /  mouse embryonic stem cells before (UNT) and after 96 hr tamoxifen (OHT) treatment demonstrates that decreases in H2AK119ub1
occur in the absence of altered RING1B occupancy. (B–C) Metaplots illustrating H2AK119ub1 and RING1B ChIP-seq read density at H2AK119ub1 peaks
with (n = 487) or without (n = 1870) significant reductions in RING1B occupancy before (UNT-solid line) and after tamoxifen treatment (OHT-dotted
line). RYBP loss affects the levels of H2AK119ub1 (B-bottom panel) even though RING1B occupancy is unaffected (B-upper panel) indicating RYBP
stimulates PRC1 activity at target sites in vivo.
DOI: 10.7554/eLife.18591.012
The following figure supplements are available for figure 6:
Figure supplement 1. RYBP deletion results in reductions in H2AK119ub1 at sites where PRC1 occupancy remains unchanged.
DOI: 10.7554/eLife.18591.013
Figure supplement 2. An examination of genomic features at PRC1 targets that retain, or lose, RING1B following deletion of RYBP/YAF2.
DOI: 10.7554/eLife.18591.014
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Figure 7. RYBP-dependent stimulation is essential for H2AK119ub1 at sites with low PRC1 occupancy. (A) A box plot illustrating the separation of
H2AK119u1 peaks into quartiles based on their relative reduction in H2AK119ub1 upon deletion of RYBP. This indicates that all H2AK119ub1 peaks
experience a decrease in H2AK119ub1 following RYBP removal, but some sites (e.g. Q1) are more dependent upon RYBP than others (e.g. Q4) (B–C)
Metaplots illustrating the RYBP and RING1B ChIP-seq read density over the H2AK119ub1 quartiles identified in (A). Quartiles that are most dependent
on RYBP for H2AK119ub1 (i.e. Q1 and Q2) have lower RYBP and RING1B occupancy. (D) A box plot illustrating that the quartiles which are most
dependent on RYBP have the largest enrichment of RYBP relative to RING1B. (E) A genomic snapshot depicting three polycomb target sites which
display varying dependencies on RYBP for their H2AK119ub1. The Gm6116 gene (highlighted in grey) has low occupancy of RING1B and CBX7, and is
almost completely reliant on RYBP for H2AK119ub1. In contrast the Gsx2 and Pdgfra genes have high RING1B and CBX7 occupancy and are less
dependent on RYBP for their H2AK119ub1. This indicates that RYBP plays a more pronounced role stimulating PRC1 activity at sites with limiting levels
of RING1B. Furthermore, sites that are highly dependent on RYBP appear to be depleted of canonical PRC1. (F) A heatmap illustrating H2AK119ub1
peaks clustered into variant-enriched PRC1 and variant and canonical PRC1 (shared) sites based on RYBP (variant PRC1) and CBX7 (canonical PRC1)
levels. Both variant-enriched and shared PRC1 target sites show a reduction in H2AK119ub1 following deletion of RYBP. (G) A box plot indicating the
alterations in H2AK119ub1 at shared or variant-enriched PRC1 target sites. The p value denotes statistical significance calculated by a Wilcoxon signed
rank test.
DOI: 10.7554/eLife.18591.015
The following figure supplement is available for figure 7:
Figure supplement 1. Gene ontology analysis of shared and variant-enriched PRC1 target sites.
DOI: 10.7554/eLife.18591.016
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targets, tended have the largest polycomb domains, and were enriched for genes related to
sequence-specific transcription factor binding (Figure 7—figure supplement 1), perhaps reflecting
a contribution of both variant and canonical PRC1 in shaping H2AK119ub1 at these regulatory
genes. Interestingly, and in contrast to previous reports (Morey et al., 2013), our ChIP-seq based
analysis of RYBP binding did not reveal a class of PcG target sites that were enriched for canonical
PRC1 (CBX7) but lacked variant PRC1 (RYBP). This suggests that canonical PRC1 binding occurs at
PcG target sites that are also occupied by variant PRC1. Together, our detailed genome-wide analy-
sis in vivo establishes a clear role for RYBP in stimulating the H2AK119ub1 E3 ligase activity of PRC1,
particularly at variant PRC1-enriched sites with low levels of RING1B.
RYBP-dependent H2AK119ub1 shapes PRC2 activity
We and others have recently discovered that PRC1 can regulate the targeting of PRC2 through its
capacity to recognize H2AK119ub1 (Blackledge et al., 2014; Cooper et al., 2014; Kalb et al.,
2014). This, coupled with CBX-dependent recognition of H3K27me3 by canonical PRC1 complexes
(Bernstein et al., 2006; Fischle et al., 2003; Min et al., 2003), could effectively create a feedback
mechanism sufficient to help sustain Polycomb chromatin domains in a histone modification-depen-
dent manner. Given that RYBP stimulates the E3 ligase activity of PRC1, we wondered whether this
activity may play a role in these proposed feedback mechanisms. To address this we performed
ChIP-seq for SUZ12, a core component of PRC2, and H3K27me3 in the Rybpfl/fl;Yaf2 /  cells before
and after tamoxifen treatment (Figure 8A). Strikingly, deletion of RYBP resulted in genome-wide
reductions in H3K27me3 at Polycomb target sites (Figure 8A and B). However, like H2AK119ub1,
H3K27me3 reductions were not evident from western blot analysis of total histones, suggesting that
H3K27me3 is affected most profoundly at classical Polycomb target sites and not the larger pool of
H3K27me3 which is proposed to exist elsewhere in the genome (Figure 8—figure supplement 1)
(Grzybowski et al., 2015). Importantly, H3K27me3 reductions at Polycomb target sites occurred
without any apparent loss in the chromatin occupancy of the PRC2 component SUZ12 (Figure 8A
and C, Figure 8—figure supplement 2), suggesting that the observed decreases in H3K27me3
likely arise as a result of reduced activity of the PRC2 complex. Like the observed changes in
H2AK119ub1 (Figure 7F and G), the largest reductions in H3K27me3 were evident at variant-
enriched PRC1 target sites (Figure 8D), consistent with a more defined role for RYBP in maintaining
PcG-associated histone marks at these regions. Importantly, reductions in H3K27me3 across all
PRC1 target sites correlated closely with reductions in H2AK119ub1 (Figure 8E), indicating that the
effects on H2AK119ub1 and H3K27me3 are linked and directly related to the activity of RYBP. These
important observations demonstrate that RYBP-dependent H2AK119ub1 shapes the activity of PRC2
in depositing H3K27me3, and suggests that the observed stimulation of PRC2 by nucleosomes con-
taining H2A mono-ubiquitylation in vitro is also relevant in vivo (Kalb et al., 2014).
Given that PRC1 and PRC2 complexes recognize and bind to the histone modifications that they
place, it was somewhat surprising to us that the reductions in H2AK119ub1 and H3K27me3 following
RYBP/YAF2 deletion did not result in more widespread effects on PRC1 and PRC2 occupancy. One
possible explanation is that normal PcG protein occupancy can only be effectively maintained as
long as histone modifications remain above a certain level or threshold. Conversely, if this threshold
is crossed, effective Polycomb chromatin occupancy may no longer be maintained, and the Poly-
comb chromatin domain could begin to erode. If this were the case, one might predict that thresh-
olds for Polycomb domain erosion would differ between individual target sites. We therefore
hypothesized that in the context of our experiments, erosion of Polycomb chromatin domains follow-
ing RYBP deletion might occur at the sites that experienced the greatest relative reductions in their
Polycomb-associated histone modifications. To examine whether this was the case, we examined the
subset of Polycomb target sites that experienced significant losses in PRC1 and PRC2 occupancy fol-
lowing RYBP deletion, and compared these to target sites at which occupancy was unaffected. Inter-
estingly, we observed that the sites with the most profound losses of H2AK119ub1 and H3K27me3
were the same sites that showed reductions in PRC1 and PRC2 (Figure 8F). Together these observa-
tions reveal two important and fundamental features associated with the function of Polycomb chro-
matin domains. Firstly, there is an intimate relationship between the histone-modifying activities of
PRC1 and PRC2 at target sites, which is regulated by auxiliary PcG complex subunits and not simply
dictated by occupancy of PRC1/PRC2 core catalytic subunits. This is evident in instances where
RYBP removal leads to reductions in both H2AK119ub1 and H3K27me3, without major alterations in
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Figure 8. RYBP-dependent H2AK119ub1 shapes PRC2 activity. (A) A genomic snapshot of H3K27me3, SUZ12 and H2AK119ub1 ChIP-seq in Rybpfl/fl;
Yaf2 /  mouse embryonic stem cells before (UNT) and after tamoxifen (OHT) treatment. At these target sites there are reductions in H3K27me3 in the
absence of changes in SUZ12 occupancy following RYBP deletion. (B-C) Metaplots illustrating ChIP-seq read density for H3K27me3 (B) and SUZ12 (C) in
the Rybpfl/fl;Yaf2 /  mouse embryonic stem cells before (UNT-solid line) and after tamoxifen (OHT-dotted line) treatment. Removal of RYBP results in
widespread loss of H3K27me3 despite largely unaffected occupancy of SUZ12. (D) A box plot indicating the alterations in H3K27me3 at shared or
variant-enriched PRC1 target sites. The p value denotes statistical significance calculated by a Wilcoxon signed rank test. (E) A scatter plot showing
changes in H2AK119ub1 and H3K27me3 normalised read densities at H2AK119ub1 peaks after deletion of RYBP. This illustrates that the fold change in
H2AK119ub1 and H3K27me3 are related to each other at individual sites following loss of RYBP. R2 and cor denote coefficient of determination for
linear regression model and the pearson correlation coefficient respectively. (F) A box plot illustrating the changes in H2AK119ub1 and H3K27me3 at
H2AK119ub1 peaks divided into groups based on whether RYBP deletion resulted in no significant loss of RING1B or SUZ12 (No Sig Loss, n = 1947),
loss of RING1B only (4RING1B, n = 319), loss of SUZ12 only (4SUZ12, n = 38) or loss of both RING1B and SUZ12 (4RING1B 4SUZ12, n = 103). This
indicates that sites susceptible to loss of RING1B and/or SUZ12 experience the greatest relative reductions in H2AK119ub1 and H3K37me3.
DOI: 10.7554/eLife.18591.017
The following figure supplements are available for figure 8:
Figure supplement 1. Analysis of H3K27me3 levels following loss of RYBP/YAF2.
DOI: 10.7554/eLife.18591.018
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PcG complex occupancy. Secondly, the occupancy of PcG complexes at target sites is not driven in
a linear fashion by H2AK119ub1 and H3K27me3 levels. However, if activity-based communication
between the PcG complexes is compromised there appears to be a modification threshold below
which complex occupancy can no longer be sustained. Again this is evident following RYBP removal,
where sites displaying the greatest loss of H2AK119ub1 and H3K27me3 also show reductions in PcG
complex occupancy.
Loss of RYBP culminates in gene reactivation at sites where Polycomb
chromatin domains are compromised
Studies in mice have demonstrated that RYBP plays a fundamental role in early development
(Pirity et al., 2005), and that it is also important at later developmental stages including haemato-
poiesis (Cale´s et al., 2016), presumably due to its involvement in PcG-mediated gene regulation
(Tavares et al., 2012). Furthermore, RYBP-deficient Drosophila die at varying stages during devel-
opment and RYBP can function as an enhancer of PcG phenotypes (Gonzalez et al., 2008). Given
the widespread effects that RYBP has on shaping H2AK119ub1 and H3K27me3, and the erosion of
normal Polycomb chromatin domains that ensues at some target sites following RYBP removal, we
wondered whether genes associated with these target sites were aberrantly transcribed. To this end,
we isolated nuclear RNA from cells before and after RYBP deletion and carried out RNA-seq analy-
sis. This revealed that loss of RYBP resulted in a limited number of robust and statistically significant
transcriptional changes (Figure 9A), in agreement with previous studies examining gene expression
by microarray analysis in RYBP deleted cells (Hisada et al., 2012). Consistent with a role for RYBP in
shaping PRC1-dependent gene repression, more genes were significantly upregulated (n = 230)
than downregulated (n = 37), and these tended to be lowly expressed genes (Figure 9A). Further-
more, when we compared these gene expression changes to those observed in the complete
absence of PRC1 activity (RING1A / ;RING1B / ) (Schoenfelder et al., 2015), most RYBP-repressed
genes fell within the set of genes that are also regulated by RING1A/B (Figure 9B). In addition,
when we compared the expression of genes that were upregulated following RYBP loss to the gene
expression changes in cells where RING1B was catalytically inactivated (RING1B I53A)
(Illingworth et al., 2015), RYBP-dependent genes were also partially upregulated, although the
effects in this context were modest (Figure 9—figure supplement 1). The extent of gene reactiva-
tion at Polycomb target genes following RYBP removalwas generally of lower magnitude than gene
reactivation following deletion of RING1A/RING1B (Figure 9C), in agreement with our observations
that RYBP stimulates, but is not absolutely required for, PRC1 activity and occupancy. Furthermore,
both shared and variant-enriched PRC1 target sites were subject to reactivation following removal of
RYBP (Figure 9—figure supplement 2).
Having identified the genes that were most dependent on RYBP for transcriptional repression, we
were keen to examine how these effects on transcription were related to any associated Polycomb
chromatin domains. We reasoned that if the integrity of a Polycomb chromatin domain was required
for normal transcriptional repression, one might expect that gene reactivation following RYBP loss
would correspond to sites where there was a loss of PcG complex occupancy. Indeed, when we
examined individual RYBP-dependent genes, increased transcription was often coincident with TSS-
associated decreases in PcG complex occupancy (Figure 9D), although this was more apparent for
PRC1 than PRC2 (Figure 9E; Figure 9—figure supplement 3). When we extended this analysis
genome-wide there was a very clear relationship, albeit not perfectly linear, between reduction of
PRC1 occupancy at TSSs and increased gene expression (Figure 9F). Consistent with a role for PcG
systems in helping to maintain genes in a repressed state in tissues where they should not normally
be expressed (Klose et al., 2013; Riising et al., 2014; Voigt et al., 2013), the magnitude of gene
reactivation events was often modest. This likely reflects genes that are in a very lowly transcribed or
off state, transitioning to a more transcribed but not fully activated state. This is presumably because
Figure 8 continued
Figure supplement 2. RYBP deletion results in reductions in H3K27me3, without decreases in PRC2 occupancy.
DOI: 10.7554/eLife.18591.019
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Figure 9. Loss of RYBP culminates in gene reactivation at sites where Polycomb chromatin domains are compromised. (A) An MA plot illustrating
differential gene expression analysis based on nuclear RNA (nucRNA)-seq in the Rybpfl/fl;Yaf2 /  mouse embryonic stem cells before and after
tamoxifen treatment. Log2 fold change of nucRNA is plotted against mean transcriptional level in wildtype cells. Significance values represent adjusted
p values calculated by DESeq2. (B) A Venn diagram illustrating that genes upregulated after deletion of RYBP are a subset of genes upregulated upon
deletion of the PRC1 catalytic core proteins RING1A/RING1B. (C) A box plot comparing the log2 fold change in nucRNA levels following loss of RYBP
or RING1A/RING1B at TSS marked by H2AK119ub1 peaks (PcG; n = 1490) or TSS without H2AK119ub1 (Non-PcG; n = 12,911). This reveals that
Polycomb target TSS are the most affected genes, and that the average level of upregulation after loss of RYBP is less than the upregulation following
deletion of RING1A/RING1B. p values denote statistical significance calculated with Wilcoxon signed rank test. (D) A genomic snapshot of two genes
upregulated following loss of RYBP. RNA-seq reads are separated by strand. Following RYBP deletion, both genes exhibit reductions in TSS-associated
RING1B and SUZ12, as illustrated by ChIP-seq for RING1B and SUZ12 before (UNT) and after tamoxifen (OHT) treatment. (E) Metaplots illustrating that
TSS occupancy of RING1B and SUZ12 are reduced after deletion of RYBP/YAF2 at upregulated genes (n = 230). (F) A scatter plot illustrating that
increases in gene expression broadly correlate with decreases in RING1B occupancy at the TSS (±500 bp). Significant reductions in RING1B are
depicted as red dots.
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the signals necessary to drive transcriptional activation of these genes are low or absent in embry-
onic stem cells.
Together, our transcription and Polycomb chromatin domain analyses reveal an activity-based
communication between PcG complexes regulated by RYBP-dependent stimulation of PRC1. Fur-
thermore it provides clear evidence that the histone modifying activities of PRC1 and PRC2 underpin
feedback mechanisms that are important for maintaining Polycomb chromatin domains
(Blackledge et al., 2015), counteracting inappropriate gene activation signals, and shaping normal
gene repression, at least at a subset of polycomb target sites.
Discussion
PcG proteins play an important chromatin-based role in controlling gene expression. The PRC1 and
PRC2 complexes work together to achieve this, and in vertebrates both their occupancy on chroma-
tin and functionality appear to rely, at least in part, on their capacity to modify histones. However,
mechanisms controlling the activity of PRC1, and its relationship with PRC2, remain poorly under-
stood. Here we reveal a defined requirement for specific PCGF components and the auxiliary subu-
nits RYBP/YAF2 in regulating the H2AK119 E3 ligase activity of PRC1 in vitro (Figures 1–4). In vivo,
RYBP plays a central role in shaping normal H2AK119ub1 at Polycomb target sites (Figure 5) where
it functions to stimulate the E3 ligase activity of PRC1 (Figures 6 and 7) and regulate PRC2-depen-
dent H3K27me3 (Figure 8). At a subset of Polycomb target sites, the absence of RYBP leads to a
more profound effect on histone modifications leading to Polycomb chromatin domain erosion (Fig-
ure 8) and inappropriate reactivation of gene expression (Figure 9). Together this extends our
understanding of the interesting and important activity-based communication between PcG com-
plexes that has been previously proposed from in vitro studies (Kalb et al., 2014), and demonstrates
that the enzymatic activity of PcG complexes can communicate through chromatin in vivo in order to
maintain normal PcG function in gene regulation.
A striking and central conclusion from our enzymatic analysis of PRC1 complexes in vitro was that
the enzymatic activity of PRC1 is determined not only by its interaction with auxiliary factors like
RYBP/YAF2 but also the PCGF protein that forms the PCGF/RING1 catalytic core. This therefore
suggests that the activity of individual PRC1 complexes is likely to depend upon the inclusion of spe-
cific PCGF proteins and to be highly regulated in vivo. An important focus for future work will be to
directly compare the E3 ligase activities of other less well-characterized PRC1 complexes, to under-
stand how widespread these regulatory mechanisms are amongst distinct PRC1 assemblies, includ-
ing those PRC1 complexes formed by PCGF3/5/6. In an important first step towards achieving this,
a recent study examined PCGF1–6/RING1 catalytic dimers and concluded that they displayed little
inherent difference in their H2AK119 E3 ligase activity on nucleosome substrates in
vitro (Taherbhoy et al., 2015). However, these experiments relied on truncated proteins which lack
important domains, including the C-terminus of RING1 which is the interaction site for RYBP/YAF2
(Wang et al., 2010). In contrast our observations using full length proteins demonstrate that PRC1
activity is governed by the nature of the catalytic dimer and the stimulatory activity of auxiliary fac-
tors like RYBP/YAF2. An important focus of future work will also rely on understanding the relative
contribution of individual PRC1 complexes in placing H2AK119ub1 in vivo, given that RYBP/YAF2
appears to interact with diverse PRC1 complexes.
As we begin to learn more about the mechanisms that shape PRC1-dependent E3 ligase activity,
our understanding of how this contributes towards PcG system function in gene regulation and
Figure 9 continued
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The following figure supplements are available for figure 9:
Figure supplement 1. A Comparison of RYBP-dependent gene expression changes with RING1BI53A gene expression changes.
DOI: 10.7554/eLife.18591.021
Figure supplement 2. Genes up-regulated following deletion of RYBP/YAF2 are not unique to shared or variant-enriched PRC1 target sites.
DOI: 10.7554/eLife.18591.022
Figure supplement 3. Genes that are reactivated in response to RYBP deletion exhibit polycomb domain erosion.
DOI: 10.7554/eLife.18591.023
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development remains an important and outstanding question. Indeed, it still remains incompletely
defined how the H2AK119ub1-dependent and independent activities of PRC1 are leveraged by the
PcG systems to regulate gene expression, particularly in mammals. However, early biochemical work
very clearly demonstrated a structural role for PRC1 in chromatin compaction and counteracting
chromatin remodelling in vitro, independently of H2AK119ub1 (Grau et al., 2011; Francis et al.,
2004). Furthermore, RING1B null cells which display transcriptional reactivation and chromatin
decompaction of the PcG-occupied Hox loci, are rescued of these deficiencies with a form or
RING1B lacking catalytic activity, suggesting a structural role on chromatin for PRC1 in this context
(Eskeland et al., 2010). In agreement with a role for canonical PRC1 in shaping chromatin structure
at PcG target sites, the PHC component of canonical PRC1 can polymerize in vitro and this activity
appears to be import for the formation of cytologically identifiable structures referred to as ‘poly-
comb bodies’ (Kim et al., 2002; Isono et al., 2013). Similar studies in Drosophila have also provided
evidence via super resolution imaging that Polycomb body formation relies on Ph (orthologous to
mammalian PHC) to shape chromatin domains (Boettiger et al., 2016; Wani et al., 2016) and per-
turbation of Ph in Drosophila leads to widespread effects on normal gene repression
(Lagarou et al., 2008). This abundance of work clearly indicates that PRC1 has essential structure-
based effects on chromatin that are related to normal PcG-dependent gene regulation and in some
cases this appears to be independent of the E3 ligase activity of PRC1. Consistent with
H2AK119ub1-independent roles for PRC1 in normal Drosophila development, a catalytic mutant of
the Drosophila RING1 orthologue (Sce1) is less phenotypically severe than that of Sce1 null animals
(Pengelly et al., 2015). Furthermore, mutation of histone H2A such that it is no longer a target for
PRC1-dependent mono-ubiquitylation did not lead to Hox gene misregulation in Drosophila imagi-
nal disc clones, suggesting that H2A ubiquitylation is not required to maintain repression of these
PcG target genes (Pengelly et al., 2015). Similarly a Ring1bI53A/I53A mouse model, in which the E3
ligase activity of RING1B-containing PRC1 complexes is perturbed, indicated that the catalytic activ-
ity of RING1B is also not essential for early mouse development, with Ring1bI53A/I53A mice succumb-
ing to embryonic lethality at a later embryonic stage than Ring1b-null mice (Illingworth et al., 2015;
Voncken et al., 2003). Because these Ring1b mouse models do not completely phenocopy each
other it would suggest that RING1B may contribute functions during mammalian development that
are independent of H2A mono-ubiquitylation, possibly related to its role in chromatin compaction
(Eskeland et al., 2010; Francis et al., 2004). However, it still remains unclear whether early mamma-
lian development and normal polycomb mediated repression can be sustained in the absence of
PRC1 E3 ligase activity, as this requires the generation of a mouse model that lacks the enzymatic
activity of RING1A and RING1B, both of which are expressed in early development and contribute
to deposition of H2AK119ub1 and gene repression (de Napoles et al., 2004; Endoh et al., 2008).
Interestingly, however, Ring1bI53A/I53A embryonic stem cells have dramatically reduced levels of
H2AK119ub1, show reductions in H3K27me3 and reactivate a subset of PcG target genes
(Illingworth et al., 2015). This scenario is reminiscent of the reductions in H2AK119ub1 and
H3K27me3 that occur following loss of RYBP-dependent stimulation of PRC1. Together these obser-
vations support the general argument that in mammals H2AK119ub1 helps to shape communication
between PRC1 and PRC2 in order to sustain normal Polycomb chromatin domain function in gene
regulation. However it is clear that a more detailed analysis of both RING1A and RING1B activity will
be imperative in defining how important H2AK119ub1 is for mammalian development and gene reg-
ulation by the PcG system.
PRC1 and PRC2 complexes have the capacity to recognise H2AK119ub1 and H3K27me3, and it
has been proposed that this supports PcG protein binding to chromatin (Blackledge et al., 2015;
Kalb et al., 2014; Margueron et al., 2009; Min et al., 2003; Wang et al., 2004b; Simon and King-
ston, 2013). Here we show that RYBP deletion causes reductions in H2AK119ub1 and H3K27me3
yet PRC1 and PRC2 occupancy remains largely intact. However, a subset of PcG target sites exhibit
larger reductions in H2AK119ub1 and H3K27me3 and have pronounced losses of PcG complex
occupancy. Based on these observations we speculate that activity-based communication between
PRC1 and PRC2 may support PcG complex occupancy through a histone modification-dependent
thresholding mechanism. In the context of such a mechanism we speculate that the majority of PcG
target genes have H2AK119ub1 and H3K27me3 levels that are in excess of that required to support
normal PRC1 and PRC2 binding. However, if H2AK119ub1 and H3K27me3 levels fall below a given
threshold, as some sites do in the absence of RYBP, normal activity-based communication between
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PRC1 and PRC2 can no longer be maintained, leading to a reduction in PcG protein occupancy and
an increased propensity for gene reactivation.
If histone modification-dependent thresholding mechanisms contribute at least at some sites to
the function of the Polycomb system, how or why might this be beneficial to the control of gene
expression? Given the highly dynamic nature of PRC1 and PRC2 interactions with chromatin
(Fonseca et al., 2012), histone modifications could provide a form of local epigenetic memory to
bridge the intervening time between individual engagement events to reinforce PcG protein occu-
pancy. Assuming that PcG protein occupancy is important for gene repression and that histone mod-
ifications can stabilize PcG protein binding, it would seem sensible that some fluctuation in histone
modification levels would need to be tolerated in order to protect the stability of the PcG system at
individual sites. However, this hysteresis could be rapidly counteracted by altering the activity of
individual PcG complexes, or by removing their associated histone modifications. In both scenarios
this would impair PcG complex occupancy and render these normally inactive states reversible and
responsive to strong gene activation signals during cell lineage commitment. In combination with
chromatin-modifying activities of the Trithorax group systems that are associated with gene activa-
tion, this could support a form of chromatin bistability at gene regulatory elements, as we and others
have previously proposed, to allow switch-like activation of gene expression (Deaton and Bird,
2011; Klose et al., 2013; Steffen and Ringrose, 2014; Voigt et al., 2013). Interestingly, alterations
in the histone modifying activities of PcG complexes are key molecular defects associated with vari-
ous cancers, suggesting that perturbing PcG-associated histone modifications, or potentially altering
histone modification thresholds, may be important in the pathological adaptation of gene expression
in cancer (Scelfo et al., 2015). Clearly more work is required to understand the relative contributions
of the histone modification-dependent and -independent activities of PcG complexes to both chro-
matin structure and gene repression at polycomb chromatin domains.
In conclusion, our enzymatic analysis of PRC1 in vitro and genomic dissection of how RYBP shapes
its activity in vivo, reveal an interesting activity-based communication between Polycomb repressive
complexes on chromatin. Furthermore, they indicate that histone modification thresholds could play
an important and previously unrealized role in shaping Polycomb chromatin domain function in the
context of gene regulation.
Materials and methods
Protein expression and purification
Mouse Ring1b, Pcgf1, Rybp, Bcor and Kdm2b (short isoform) were cloned into the Multibac plasmid
set. Acceptor and donor plasmids were recombined using Cre recombinase (NEB, Ipswich, MA) as
previously described (Bieniossek et al., 2012) and transfected into SF21 cells to make infectious
baculovirus particles. Baculoviruses were then used to express proteins in SF21 cells. Baculovirus
expressed proteins were then extracted and affinity purified via a FLAG-tagged RING1B subunit on
FLAG affinity resin (Sigma, St Louis, MO) and eluted under native conditions using a 1x FLAG pep-
tide (GL Biochem, Shanghai, China) with the lysis buffer containing 10 mM Tris (pH 8.0), 500 mM
NaCl, 4 mM MgCl2, 2 mM DTT, 20% glycerol (v/v), cOmplete Protease Inhibitor Cocktail (Roche,
UK), wash buffer containing 20 mM HEPES (pH 7.9), 150 mM NaCl, 2 mM MgCl2, 1 mM DTT, 15%
glycerol (v/v), cOmplete Protease Inhibitor Cocktail, dilution buffer containing 10 mM Tris (pH 8.0),
10% glycerol (v/v), 0.02 % NP-40, and elution buffer consisting of wash buffer with 0.2 mg/mL 1x
FLAG peptide. Mouse Rybp and Yaf2 were cloned into pNIC28 and transformed into E. coli Rosetta2
cells; mutagenesis of Rybp was carried out using the QuikChange II mutagenesis kit (Agilent). His-
tagged proteins were purified on Co-Talon resin using the same buffers as for FLAG purification, but
with the exception of DTT and the addition of 10 mM imidazole to the wash buffer, and 150 mM
imidazole to the elution buffer instead of FLAG peptide. This was followed by anion exchange chro-
matography (HiTrap Q FF; GE Healthcare, UK).
Crosslinking mass spectrometry
Protein crosslinking was carried out as previously described (Leitner et al., 2014). 30 mg of PRC1
protein complex was crosslinked with BS3 (Creative Molecules) for 30 min at 37˚C. The concentration
of BS3 was optimised for each complex to prevent over-crosslinking as analysed by SDS-PAGE.
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Crosslinking reactions were quenched with 1 M NH4HCO3 to a final concentration of 50 mM and
incubated at 37˚C for 20 min. Crosslinking reactions were then evaporated to near-dryness in a vac-
uum centrifuge, and urea was then added to a final concentration of 6 M. Disulfide bonds were
reduced with TCEP for 30 min at 37˚C, followed by iodoacetamide treatment for 30 min at room
temperature in the dark, and the reaction mixture was then diluted with 50 mM NH4HCO3 to a final
concentration of 1 M urea. Samples were then digested overnight with trypsin (Promega, Madison,
WI) at a 1:50 enzyme:substrate ratio, desalted using a C18 Sep-pak cartridge (Waters, UK) and evap-
orated to dryness before being resuspended in 70% H2O/30% ACN/0.1% TFA and subjected to gel
filtration using a Superdex Peptide 10/300 GL column (GE Healthcare). Peak fractions corresponding
to crosslinked peptides were then combined and analysed by liquid chromatography tandem mass
spectrometry (LC-MS/MS) using an Orbitrap Elite (ThermoScientific, Waltham, MA) as described pre-
viously (Adam et al., 2011). MZXML data files were analysed using the XQuest software package as
described (Leltner et al., 2014). Data were represented using Circos with crosslinks weighted by
confidence score (generated by XQuest). A confidence score cut-off > 15 was chosen by a combina-
tion of FDR < 10% and validation of crosslinks wherever possible using known proximities from crys-
tal structures (lysine a-carbons separated by <27 A˚).
Reconstitution of nucleosomes
Nucleosomes were reconstituted as previously described (Dyer et al., 2004). Recombinant Xenopus
histones were expressed in E. coli BL21(DE3) pLysS and purified from inclusion bodies via Sephacryl
S-200 gel filtration (GE Healthcare). Stoichiometric amounts of each core histone were incubated
together under high salt conditions (2 M NaCl) and the resulting histone octamer purified using a
Superdex 200 gel filtration column (GE Healthcare). 216 bp DNA carrying the nucleosome-position-
ing 601 sequence was PCR amplified from the pGEM-3Z 601 plasmid and purified using a Resource
Q anion exchange column (GE Healthcare). Purified DNA, in slight excess to octamers, was mixed
together in 2 M NaCl and diluted stepwise with 10 mM Tris (pH 7.5) to reach a final concentration of
100 mM NaCl. The reconstituted nucleosomes were then analysed on a 0.8% Tris-borate agarose
gel, and concentrated using a 5000 MWCO spin concentrator (GE Healthcare).
E3 ligase assays
E3 ligase assays were performed in the presence of reconstituted PRC1 and nucleosomes, with the
addition of UBE1 (Boston Biochem), UbcH5c (Boston Biochem), methylated ubiquitin (Boston Bio-
chem) and ATP (Life Technologies). Concentrations of E1, E2 and ubiquitin were pre-optimised such
that reactions were pseudo-first order with respect to PRC1. Ubiquitylation reactions were carried
out in 50 mM Tris (pH 7.5), 2.5 mM MgCl2 and 0.5 mM DTT. E1, E2, ubiquitin and ATP were pre-
incubated for 20 min at 37˚C, followed by addition of PRC1 and nucleosomes (0.35 mM final concen-
tration), and then incubated at 37˚C for 1 hr. Reactions were quenched with 5 mM EDTA and SDS-
PAGE loading buffer (2% SDS, 100 mM Tris-HCl (pH 6.8), 100 mM DTT, 10% glycerol, 1 mg/mL bro-
mophenol blue), boiled for 5 min, and loaded onto SDS-PAGE gels for western blot analysis. West-
ern blots were probed with antibodies specific for histone H2AK119ub1 (Farcas et al., 2012) or
histone H2A (Millipore 07–146), followed by incubation with LiCOR IRDye secondary antibodies
(800CW goat anti-rabbit and goat anti-mouse). Westerns were imaged using the LiCOR Odyssey Fc
imaging system, and the fraction of H2AK119ub1 relative to total H2A (non-ubiquitylated H2A plus
H2AK119ub1) was quantified. Data were visualised and dose-response curves fitted using GraphPad
Prism 6.0.
Generation of Rybpfl/fl;Yaf2 /  conditional KO embryonic stem cells
Rybpfl/fl mouse embryonic stem cells, which were previously described and validated (Hisada et al.,
2012), were grown in DMEM (Gibco, Carlsbad, CA) supplemented with 15% FBS, 10 ng/mL leuke-
mia-inhibitory factor, penicillin/streptomycin, beta-mercaptoethanol, L-glutamine and non-essential
amino-acids. Within our laboratory, cells were regularly tested to ensure the absence of mycoplasma
contamination. sgRNAs for Yaf2 (Guide 1: TCTGATCGAGGGGCGACTTT; Guide 2: CGCA
TGGAACGGCACGGCAC) were cloned into pSpCas9(BB)-2A-Puro (plasmid 48139; Addgene, Cam-
bridge, MA) using a previously described protocol (Ran et al., 2013). Cells were transfected with
Cas9-sgRNA plasmids using Lipofectamine 3000 (Life Technologies), followed by puromycin
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selection (1 mg/mL) for 48 hr. Individual colonies were isolated after approximately 10 days,
expanded and screened by PCR for the deletion of Yaf2 exons 1 and 2. Deletion of Yaf2 mRNA and
protein was confirmed by qRT-PCR and Western Blot, using a YAF2-specific antibody (Park et al.,
2015). Rybpfl/fl;Yaf2-/- cells were treated with 800 nM 4-hydroxytamoxifen (OHT) for 96 hr to condi-
tionally delete RYBP, which was verified by Western Blot (Millipore AB3637).
Chromatin immunoprecipitation
Chromatin immunoprecipitation was performed as described previously (Farcas et al., 2012), with
minor modifications. For non-histone ChIP experiments, cells were fixed for 1 hr in 2 mM EGS, fol-
lowed by 15 min in 1 % formaldehyde. Reactions were quenched by the addition of glycine to a final
concentration of 125 mM. After cell lysis and chromatin extraction, chromatin was sonicated using a
BioRuptor sonicator (Diagenode), followed by centrifugation at 16,000  g for 20 min at 4˚C. For his-
tone ChIP experiments we used a native ChIP protocol combined with a calibrated ChIP-seq
approach, as previously described (Bonhoure et al., 2014; Hu et al., 2015; Orlando et al., 2014).
To achieve this, 1.25  107 Drosophila melanogaster S2 cells were spiked in to 5  107 Rybpfl/fl;
Yaf2-/- mouse embryonic stem cells with or without OHT treatment. Nuclei were then isolated with
RSB buffer (10 mM Tris-HCl (pH 8), 10 mM NaCl, 3 mM MgCl2) supplemented with 0.1 % NP-40 and
5 mM N-ethylmaleimide, followed by MNase digestion for 5 min with 150 U MNase (Fermentas, Wal-
tham, MA) in 1 ml RSB supplemented with 0.25 M sucrose, 3 mM CaCl2 and 10 mM N-ethylmalei-
mide. Digestions were stopped with EDTA, before nuclei were pelleted by centrifugation at 1500 x
g and the soluble S1 fraction collected. Pelleted nuclei were then resuspended in 300 ml nucleosome
release buffer (10 mM Tris-HCl (pH 7.5), 10 mM NaCl, 0.2 mM EDTA, 10 mM N-ethylmaleimide),
incubated at 4˚C for 1 hr with gentle rotation, and then gently passed through a 27G syringe needle
five times. Following centrifugation to pellet the insoluble material, the soluble S2 fraction was col-
lected and combined with the S1 fraction.
Immunoprecipitations were performed overnight at 4˚C using chromatin corresponding to 5 
106 cells. For non-histone ChIP experiments, chromatin was diluted in ChIP dilution buffer (1% Tri-
ton-X100, 1 mM EDTA, 20 mM Tris-HCl (pH 8), 150 mM NaCl), while for histone ChIPs, combined
S1/S2 fractions were diluted in native ChIP incubation buffer (70 mM NaCl, 10 mM Tris (pH 7.5), 2
mM MgCl2, 2 mM EDTA, 0.1% Triton). Immunoprecipitations were carried out in a total volume of 1
ml using approximately 3 mg of antibody. Antibodies used for ChIP experiments were anti-
H2AK119ub1 (Cell Signalling D27C4), anti-H3K27me3 (generated in-house), anti-RYBP (Millipore
AB3637), anti-RING1B (Cell Signalling D22F2) and anti-SUZ12 (Cell Signalling D39F6). Antibody-
bound chromatin was isolated on protein A agarose beads (RepliGen, Waltham, CA) or protein A
magnetic Dynabeads (Invitrogen, Carlsbad, CA). For non-histone ChIPs, washes were performed
with low salt buffer (0.1% SDS, 1% Triton, 2 mM EDTA, 20 mM Tris-HCl (pH 8.1), 150 mM NaCl),
high salt buffer (0.1% SDS, 1% Triton, 2 mM EDTA, 20 mM Tris-HCl (pH 8.1), 500 mM NaCl), LiCl
buffer (0.25 M LiCl, 1% NP40, 1% sodium deoxycholate, 1 mM EDTA, 10 mM Tris-HCl (pH 8.1)) and
TE buffer (x2 washes) (10 mM Tris-HCl (pH 8.0), 1 mM EDTA). Native histone ChIPs were instead
washed four times with native ChIP wash buffer (20 mM Tris-HCl (pH 7.5), 2 mM EDTA, 125 mM
NaCl and 0.1% Triton), followed by a final TE buffer wash. To prepare ChIP-seq material, ChIP DNA
was eluted, and cross-links reversed at 65˚C in the presence of 200 mM NaCl where required. Sam-
ples were then treated with RNase and proteinase K before being purified with ChIP DNA Clean
and Concentrator kit (Zymo, Irvine, CA). For calibrated ChIP-seq experiments, an input control was
prepared for each individual sample, to allow the quantitation of spike-in consistency.
Massively parallel sequencing, data processing and normalisation
ChIP-seq libraries were prepared using the NEBNext Ultra DNA Library Prep Kit, and sequenced as
40 bp paired-end reads on Illumina NextSeq500 platform. All ChIP-seq experiments were carried
out in biological triplicate. To analyse the ChIP-seq experiments, reads were aligned to the mouse
mm10 genome using bowtie2 (Langmead and Salzberg, 2012) with the ’-no-mixed’ and ’-no-discor-
dant’ options, and non-uniquely mapping reads were discarded. ChIP-seq experiments which con-
tained a spike-in genome (D. melanogaster) were aligned against a concatenated genome of the
two genome sequences (mm10+dm6), and reads which mapped more than once were discarded.
PCR duplicates were removed using SAMtools (Li et al., 2009).
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Spiking an identical concentration of D. melanogaster cells into our quantitative ChIP-seq experi-
ments allows for calibration of each sample for IP efficiency and total mouse cell number. When
comparing ChIP-seq for untreated and OHT-treated cell lines using an internal calibration, the num-
ber of mm10 reads were randomly downsampled to reflect the total number of dm6 reads in that
sample. Furthermore, to adjust for variation in the dm6/mm10 ratio between biological replicates,
each sample was adjusted using the percentage of dm6 reads relative to mm10 reads in each sam-
ple’s input DNA. Biological replicates for ChIP-seq samples without internal spike-in were randomly
downsampled to contain the same number of reads for each individual replicate. Genome coverage
tracks were made using the pileup function of MACS2 (Zhang et al., 2008) and visualised using the
UCSC genome browser.
Peak calling, read count quantitation and analysis
We identified regions of H2AK119ub1 enrichment using the dpeak function of DANPOS2 (-q 40 –kw
750 –kd 1500, height_logP > 100) (Chen et al., 2013) and peaks closer than 5 kilobases were
merged. RING1B, SUZ12 and H3K27me3 peaksets were generated using MACS2 (-broad), and
peaks closer than 2 kilobases were merged. Read counts within intervals were generated using cus-
tom script GFF.ReadCountFromList.pl. For non-calibrated ChIP-seq, reads per kilobase per million
(RPKM) were calculated, while for calibrated ChIP-seq, normalised reads per kilobase (NRPK) were
calculated (after normalisation to calibration genome). For each interval, biological triplicate NRPK
or RPKM values were compared between untreated and OHT-treated samples using a two-sample
T-Test, with a p value threshold of <0.05 being used to identify significant difference. Log2 fold
change values were visualised using R (v 3.2.1), with scatterplots coloured by density using stat_den-
sity2d. Regression and correlation analyses were also performed in R using standard linear models
and Pearson correlation respectively. Metaplots were made using HOMER (version 2) (Heinz et al.,
2010), Heatmaps and genome-wide correlation analyses were generated using deepTools2.
Identification of variant-enriched and shared PRC1 target sites
A ±10 kb window centred on H2AK119ub1 intervals was provided to deepTools2 for k-means clus-
tering based on RYBP (this study) and CBX7 (Morey et al., 2013) ChIP-seq (Ryan et al., 2016). This
generated two clusters, variant-enriched (RYBP-enriched but CBX7-depleted) and shared (RYBP- and
CBX7-enriched).
Nuclear RNA-seq sample generation and analysis
1  107 Rybpfl/fl;Yaf2 /  cells with or without OHT were resuspended in 1 mL HS Lysis buffer (50
mM KCl, 10 mM MgSO4.7H20, 5 mM HEPES, 0.05% NP40 (IGEPAL CA630)), 1 mM PMSF, 3 mM
DTT) for 1 min at room temperature to isolate nuclei. Nuclei were centrifuged at 1000  g for 5 min
at 4˚C, followed by a total of three washes with ice-cold RSB buffer. Nuclei were then resuspended
in 1 mL of TriZOL reagent (ThermoScientific) according to the manufacturer’s protocol. Nuclear RNA
was treated with the TURBO DNA-free Kit (ThermoScientific) and depleted for rRNA using the Ribo-
Minus kit and protocol (ThermoScientific). RNA-seq libraries were prepared using the NEBNext Ultra
Directional RNA-seq kit (NEB) and libraries were sequenced on the Illumina NextSeq500 with 40 bp
paired-end reads.
RNA-seq reads were initially aligned against the rRNA genomic sequence (GenBank: BK000964.3)
using bowtie2 to filter out rRNA fragments, prior to alignment against the mm10 genome using the
STAR RNA-seq aligner (Dobin et al., 2013). To improve mapping of nascent, intronic sequences,
reads which failed to map using STAR were aligned against the genome using bowtie2. Biological
triplicate read counts were determined using a custom script (GFF_PairedEndRNA.ReadCount.pl)
for a custom-built, non-redundant mm10 gene set. Briefly, mm10 refGene genes were filtered on
size (>200 bp), gene body and TSS mappability, unique TSS and TTS, in order to remove poorly
mappable and highly similar transcripts. The final set of 20,633 genes were used for differential anal-
ysis using DESeq2 (Love et al., 2014), with default settings and a significance threshold of
padj < 0.05. Previously published nuclear RNA-seq from RING1Bfl/fl;RING1A-/- was aligned and proc-
essed in an identical manner (Schoenfelder et al., 2015). Statistical significance between Polycomb
target TSS and non-Polycomb TSS was assessed using Wilcoxon signed rank test. Venn diagram
overlap of significantly increased genes was performed using BioVenn (Hulsen et al., 2008).
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Accession numbers
ChIP-seq and RNA-seq data from the present study are available for download at GSE83135. Previ-
ously published datasets used for analysis include wildtype embryonic stem cell (E14) H3K4me3 from
the ENCODE project (GSE31039), CBX7 ChIP-seq (GSE42466; Morey et al., 2013), RNA polymerase
II ChIP-seq (GSE34520; Brookes et al., 2012), MNase-seq (GSE59064; Anderson and Slotkin,
1975); RING1A-/-;RING1Bfl/fl nuclear RNA-seq (E-MTAB-3125; Schoenfelder et al., 2015) and
RING1BI53A mutant (GSE69978; Illingworth et al., 2015).
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